Other formats:
BibTeX
LaTeX
RIS
@article{1394356,
author = {Brožová, Lucie and Schwarz, Daniel and Šnábl, Ivo and Kalina, Jiří and Pavlickova, B. and Komenda, Martin and Jarkovský, Jiří and Nemec, P. and Horinek, D. and Stefanikova, Z. and Pour, Luděk and Hajek, R. and Maisnar, V.},
article_location = {Praha},
article_number = {Suppl. 2},
doi = {http://dx.doi.org/10.14735/amko20172S43},
keywords = {Registry of Monoclonal Gammopathies CLADE-IS ; data visualisation; database RMG; registries; monoclonal gammopathies},
language = {eng},
issn = {0862-495X},
journal = {Klinická onkologie},
title = {Czech Registry of Monoclonal Gammopathies – Technical Solution, Data Collection and Visualisation},
url = {https://www.ncbi.nlm.nih.gov/pubmed/28903570},
volume = {30},
year = {2017}
}
TY - JOUR
ID - 1394356
AU - Brožová, Lucie - Schwarz, Daniel - Šnábl, Ivo - Kalina, Jiří - Pavlickova, B. - Komenda, Martin - Jarkovský, Jiří - Nemec, P. - Horinek, D. - Stefanikova, Z. - Pour, Luděk - Hajek, R. - Maisnar, V.
PY - 2017
TI - Czech Registry of Monoclonal Gammopathies – Technical Solution, Data Collection and Visualisation
JF - Klinická onkologie
VL - 30
IS - Suppl. 2
SP - "2S43"-"2S50"
EP - "2S43"-"2S50"
PB - Ambit Media
SN - 0862495X
KW - Registry of Monoclonal Gammopathies CLADE-IS
KW - data visualisation
KW - database RMG
KW - registries
KW - monoclonal gammopathies
UR - https://www.ncbi.nlm.nih.gov/pubmed/28903570
L2 - https://www.ncbi.nlm.nih.gov/pubmed/28903570
N2 - Background; The Registry of Monoclonal Gammopathies (RMG) was established by the Czech Myeloma Group in 2007. RMG is a registry designed for the collection of clinical data concerning diagnosis, treatment, treatment results and survival of patients with monoclonal gammopathies. Data on patients with monoclonal gammopathy of undetermined significance (MGUS), Waldenstrom macroglobulinaemia (WM), multiple myeloma (MM) or primary AL ("amyloid light-chain*) amyloidosis are collected in the registry. Data: Nineteen Czech centres and four Slovak centres currently contribute to the registry. The registry currently contains records on more than 5,000 patients with MM, almost 3,000 patients with MGUS, 170 patients with WM and 26 patients with primary AL amyloidosis, Le. more than 8,000 records on patients with monoclonal gammopathies altogether. fl«sufts;Thts paper describes technology employed for the collection, storage and subsequent online visualisation of data. The CLADE-tS platform is introduced as a new system for the collection and storage of data from the registry. The form structure and functions of the new system are described for all diagnoses in general; these functions facilitate data entry to the registry and minimise the error rate in data. Publicly available online visualisations of data on patients with MGUS, WM, MM or primary AL amyloidosis from all Czech or Slovak centres are introduced, together with authenticated visualisations of data on patients with MM from selected centres. Conclusion: The RMG represents a data basis that makes it possible to monitor the disease course in patients with monoclonal gammopathies on the population level.
ER -
BROŽOVÁ, Lucie, Daniel SCHWARZ, Ivo ŠNÁBL, Jiří KALINA, B. PAVLICKOVA, Martin KOMENDA, Jiří JARKOVSKÝ, P. NEMEC, D. HORINEK, Z. STEFANIKOVA, Luděk POUR, R. HAJEK and V. MAISNAR. Czech Registry of Monoclonal Gammopathies – Technical Solution, Data Collection and Visualisation. \textit{Klinická onkologie}. Praha: Ambit Media, 2017, vol.~30, Suppl. 2, p.~''2S43''-''2S50'', 8 pp. ISSN~0862-495X. Available from: https://dx.doi.org/10.14735/amko20172S43.
|
